OX40 T-cell costimulatory agonist BMS-986178 alone or in combination with nivolumab in patients with advanced solid tumors: initial phase 1 resultsAnthony J. Olszanski,Ignacio Melero,Michael Ong,Anna Spreafico,Kimberley Heinhuis,Richard Carvajal,Maria Ochoa de Olza,Quincy Chu,Anke Klippel,Yun Shen,Yan Feng, Bryan Barnhart,Alan Korman,Michael Quigley,Paula M. Fracasso,Praveen Aanur,Martin GutierrezJOURNAL FOR IMMUNOTHERAPY OF CANCER（2017）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
